Drug Development Research · 1992 · 108 citations · 22 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyNeuropharmacologyPharmacodynamicsAppetiteDrug-receptor InteractionsLigand BindingReceptor PharmacologySerotonergic PharmacologySerotonergic Signaling5-Hydroxytryptamine Receptor PharmacologyAgonist ActivityCompetitive SaturationPharmacology Of Serotonergic AgentsSaturationSerotonin AgonistsSerotonin PharmacodynamicsSerotonin Receptor Pharmacology
Abstract CP‐94,253, 3‐(1,2,5,6‐tetrahydro‐4‐pyridyl)‐5‐propoxypyrrolo[3,2‐ b ]pyridine, a new serotonergic ligand, was found to exhibit significantly greater binding affinity at 5‐HT 1B receptors than at 5‐HT 1A or 5‐HT 1C receptors. Saturation studies showed CP‐94,253 to be a competitive inhibitor of [ 125 l]iodocyanopindolol binding to 5‐HT 1B sites. Its competition curve with this radioligand was shifted to the right (decreased affinity) in the presence of Gpp(NH)p, indicating an agonist function for CP‐94,253. Oral administration of CP‐94,253 to rats caused inhibition of food intake, decrease in body weight gain, and hyperlocomotion, effects apparently elicited via activation of 5‐HT 1B receptors. © 1992 Wiley‐Liss, Inc.
22
J E Leysen, C. J. E. Niemegeers, Jan M. Van Nueten et al. · Molecular Pharmacology · 1982 · 1.1K citations